Table 1.

Circulating tumor cells (CTC) detected in patients with cervical cancers

Patient no.	Stage	Site of metastasis	HPV subtype primary	HPV subtype CTC	No. CTC	No. contaminated WBC	hTERT mRNA expression	Prognosis
2	IIA	no metastasis	16	16	2	0	+	NED 40 mo
4	Recurrence	Lung	33	ND	4	14	NA	Progression 7 mo, DOD 27 mo
5	IB1	no metastasis	16	16	1	2	+	NED 40 mo
6	IB1	no metastasis	16	16	3	1	NA	NED 40 mo
10	Recurrence	Lung	16a	16	4	5	NA	Progression 4 mo, DOD 5 mo
16	IB1	no metastasis	16	16	1	0	+	NED 29 mo

DOD, died of disease; HPV, human papillomavirus; hTERT, human telomerase reverse transcriptase; NA, not available; ND, not detected; NED, no evidence of disease; WBC, white blood cells.

^aThe HPV subtype was identified using the AMPLICORE^® human papilloma virus test (Roche, Basel, Switzerland).